Abstract:Prediction of the stage of cancer plays an important role in planning the course of treatment and has been largely reliant on imaging tools which do not capture molecular events that cause cancer progression. Gene-expression data-based analyses are able to identify these events, allowing RNA-sequence and microarray cancer data to be used for cancer analyses. Breast cancer is the most common cancer worldwide, and is classified into four stages - stages 1, 2, 3, and 4 [2]. While machine learning models have previously been explored to perform stage classification with limited success, multi-class stage classification has not had significant progress. There is a need for improved multi-class classification models, such as by investigating deep learning models. Gene-expression-based cancer data is characterised by the small size of available datasets, class imbalance, and high dimensionality. Class balancing methods must be applied to the dataset. Since all the genes are not necessary for stage prediction, retaining only the necessary genes can improve classification accuracy. The breast cancer samples are to be classified into 4 classes of stages 1 to 4. Invasive ductal carcinoma breast cancer samples are obtained from The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) datasets and combined. Two class balancing techniques are explored, synthetic minority oversampling technique (SMOTE) and SMOTE followed by random undersampling. A hybrid feature selection pipeline is proposed, with three pipelines explored involving combinations of filter and embedded feature selection methods: Pipeline 1 - minimum-redundancy maximum-relevancy (mRMR) and correlation feature selection (CFS), Pipeline 2 - mRMR, mutual information (MI) and CFS, and Pipeline 3 - mRMR and support vector machine-recursive feature elimination (SVM-RFE). The classification is done using deep learning models, namely deep neural network, convolutional neural network, recurrent neural network, a modified deep neural network, and an AutoKeras generated model. Classification performance post class-balancing and various feature selection techniques show marked improvement over classification prior to feature selection. The best multiclass classification was found to be by a deep neural network post SMOTE and random undersampling, and feature selection using mRMR and recursive feature elimination, with a Cohen-Kappa score of 0.303 and a classification accuracy of 53.1%. For binary classification into early and late-stage cancer, the best performance is obtained by a modified deep neural network (DNN) post SMOTE and random undersampling, and feature selection using mRMR and recursive feature elimination, with an accuracy of 81.0% and a Cohen-Kappa score (CKS) of 0.280. This pipeline also showed improved multiclass classification performance on neuroblastoma cancer data, with a best area under the receiver operating characteristic (auROC) curve score of 0.872, as compared to 0.71 obtained in previous work, an improvement of 22.81%. The results and analysis reveal that feature selection techniques play a vital role in gene-expression data-based classification, and the proposed hybrid feature selection pipeline improves classification performance. Multi-class classification is possible using deep learning models, though further improvement particularly in late-stage classification is necessary and should be explored further.

A semi-supervised deep learning method based on stacked sparse auto-encoder for cancer prediction using RNA-seq data

Deep learning-based cancer survival prognosis from RNA-seq data: approaches and evaluations

A Self-Training Subspace Clustering Algorithm under Low-Rank Representation for Cancer Classification on Gene Expression Data

A Multi-Modal Graph-Based Semi-Supervised Pipeline for Predicting Cancer Survival

Occlusion enhanced pan-cancer classification via deep learning

Machine Learning Analysis of RNA-seq Data for Diagnostic and Prognostic Prediction of Colon Cancer

Automated exploitation of deep learning for cancer patient stratification across multiple types

Analyzing RNA-Seq Gene Expression Data Using Deep Learning Approaches for Cancer Classification

Deep Learning to Analyze RNA-Seq Gene Expression Data

Tumor gene expression data classification via sample expansion-based deep learning

Stacked Autoencoder Based Multi-Omics Data Integration for Cancer Survival Prediction

Noncoding RNAs and deep learning neural network discriminate multi-cancer types

scSemiAE: a deep model with semi-supervised learning for single-cell transcriptomics

Stacked Sparse Autoencoder (SSAE) for Nuclei Detection on Breast Cancer Histopathology Images

Integrating multi-omics data through deep learning for accurate cancer prognosis prediction

A Comparison of Self-Supervised Pretraining Approaches for Predicting Disease Risk from Chest Radiograph Images

LDAEXC: LncRNA-Disease Associations Prediction with Deep Autoencoder and XGBoost Classifier

Prognostic outcome prediction by semi-supervised least squares classification

Enhancing the prediction of IDC breast cancer staging from gene expression profiles using hybrid feature selection methods and deep learning architecture

A Semi-Supervised Method for Predicting Cancer Survival Using Incomplete Clinical Data

Cancer diagnosis using generative adversarial networks based on deep learning from imbalanced data